ORBIMED ADVISORS LLC Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$8.8B
Holdings
131
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (131 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | CLLSCELLECTIS S A | 350,000 | $8.4B | 95.21% | |
| 102 | CRSPCRISPR THERAPEUTICS AG | 372,191 | $8.1B | 91.85% | |
| 103 | —IMMUNOMEDICS INC | 1,232,100 | $8.0B | 90.36% | |
| 104 | NVROEURNEVRO CORP | 77,800 | $7.3B | 82.63% | |
| 105 | —TESARO INC | 47,200 | $7.3B | 82.33% | |
| 106 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $6.8B | 77.25% | |
| 107 | SNDXSYNDAX PHARMACEUTICALS INC | 484,800 | $6.7B | 75.39% | |
| 108 | ZBHZIMMER BIOMET HLDGS INC | 49,000 | $6.0B | 67.82% | |
| 109 | NERVGBPMINERVA NEUROSCIENCES INC | 704,300 | $5.7B | 64.67% | |
| 110 | —SIERRA ONCOLOGY INC | 3,703,704 | $5.7B | 64.24% | |
| 111 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $5.4B | 61.40% | |
| 112 | NVTA1EURINVITAE CORP | 456,666 | $5.1B | 57.25% | |
| 113 | —AFFIMED N V | 2,018,900 | $4.6B | 52.63% | |
| 114 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $4.4B | 50.25% | |
| 115 | SIENUSDSIENTRA INC | 522,257 | $4.4B | 49.84% | |
| 116 | ALNYALNYLAM PHARMACEUTICALS INC | 82,200 | $4.2B | 47.75% | |
| 117 | —ROKA BIOSCIENCE INC | 893,470 | $3.2B | 36.06% | |
| 118 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $2.6B | 29.37% | |
| 119 | XENEXENON PHARMACEUTICALS INC | 634,812 | $2.5B | 28.78% | |
| 120 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 300,000 | $2.4B | 27.00% | |
| 121 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $2.1B | 24.37% | |
| 122 | AMRNAMARIN CORP PLC | 350,000 | $1.1B | 12.70% | |
| 123 | —NOVELION THERAPEUTICS INC | 100,000 | $1.1B | 12.17% | |
| 124 | —MARINUS PHARMACEUTICALS INC | 567,600 | $1.0B | 11.39% | |
| 125 | —BIOLINERX LTD | 1,038,600 | $998.0M | 11.31% | |
| 126 | VNDAVANDA PHARMACEUTICALS INC | 50,200 | $703.0M | 7.97% | |
| 127 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $593.0M | 6.72% | |
| 128 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $567.0M | 6.43% | |
| 129 | —ALIMERA SCIENCES INC | 250,000 | $350.0M | 3.97% | |
| 130 | —XTANT MED HLDGS INC | 475,439 | $296.0M | 3.36% | |
| 131 | —MEDIGUS LTD | 60,000 | $185.0M | 2.10% |
PreviousPage 2 of 2